Medprecis Journals adhere to the principles outlined below, which have been devised to ensure the accuracy, timely, fair, and ethical publication of scientific papers. The publisher regularly reviews its editorial policies. It has adopted rigorous and clear guidelines for best working practices in scientific publishing. Such policies will benefit our authors, editors, and readers as we strive for a transparent, trustworthy, and efficient publishing process. Responsibility for the journal and its policies lies with the Editor in Chief in conjunction with the Publisher; any concerns either regarding specific papers or general policies should be directed to the Academic Editor and Associate Editor. All versions of scholarly articles will remain available once published. When multiple versions of the same article are available, the publisher will ensure that these articles are clearly labeled with the date of publication and manuscript number or type.

Our Open Access Policy

Medprecis publishes the articles under open access policy. This implies that the volumes and issues can be directly accessed, the articles can be read free of cost and the information can be downloaded, printed, distributed, and shared without any limitation.

Medprecis aims at the widest possible dissemination of scholarly information. The magnitude of the impact generated by the information published in open-access mode is intensified. As a consequence, the probability of the research work getting cited is also higher providing much better recognition of the author(s) among the scientific community.

• The articles published under the open access policy are free to access online and can also be shared and reused without any restrictions by citing the original source.
• The authors retain the copyrights of their articles published under open access mode.
• Creative Commons license applies to the open-access mode of publishing.
• Under the gold open access policy, the final version of the published article is freely accessible with immediate effect.
• We provide Digital Object Identifier (DOI) for all published articles for permanent identification and location on the web.

Publication Ethics

Editors’ Responsibilities

• To act in a balanced, objective, and fair way while carrying out their expected duties, without discrimination on grounds of gender, sexual orientation, religious or political beliefs, ethnic or geographical origin of the authors.
• To handle submissions for sponsored supplements or special issues in the same way as other submissions, so that articles are considered and accepted solely on their academic merit and without commercial influence.
• To adopt and follow reasonable procedures in the event of complaints of an ethical or conflicting nature, in accordance with the policies and procedures of the Society where appropriate. To give authors a reasonable opportunity to respond to any complaints. All complaints should be investigated no matter when the original publication was approved. Documentation associated with any such complaints should be retained.

Reviewers’ Responsibilities

• To contribute to the decision-making process, and to assist in improving the quality of the published paper by reviewing the manuscript objectively, in a timely manner.
• To maintain the confidentiality of any information supplied by the editor or author. To not retain or copy the manuscript.
• To alert the editor to any published or submitted content that is substantially similar to that under review.
• To be aware of any potential conflicts of interest (financial, institutional, collaborative, or other relationships between the reviewer and author) and to alert the editor to these, if necessary, withdrawing their services for that manuscript.

Authors’ Responsibilities

• To maintain accurate records of data associated with their submitted manuscript, and to supply or provide access to these data, on reasonable request. Where appropriate and where allowed by employer, funding body, and others who might have an interest, to deposit data in a suitable repository or storage location, for sharing and further use by others.
• To confirm/assert that the manuscript as submitted is not under consideration or accepted for publication elsewhere. Where portions of the content overlap with published or submitted content, acknowledge and cite those sources. Additionally, to provide the editor with a copy of any submitted manuscript that might contain overlapping or closely related content.
• To confirm that all the work in the submitted manuscript is original and to acknowledge and cite content reproduced from other sources. To obtain permission to reproduce any content from other sources.
• Authors should ensure that any studies involving human or animal subjects conform to national, local, and institutional laws and requirements (e.g. WMA Declaration of Helsinki, NIH Policy on Use of Laboratory Animals, EU Directive on Use of Animals) and confirm that approval has been sought and obtained where appropriate. Authors should obtain express permission from human subjects and respect their privacy.
• To declare any potential conflicts of interest (e.g. where the author has a competing interest (real or apparent) that could be considered or viewed as exerting an undue influence on his or her duties at any stage during the publication process).
• To notify promptly the journal editor or publisher if a significant error in their publication is identified. To cooperate with the editor and publisher to publish an erratum, addendum, corrigendum notice, or to retract the paper, where this is deemed necessary.

Competing Interests

Medprecis Publishers requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘competing interests' section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read “The authors have declared that no competing interests exist.” Editors may ask for further information relating to competing interests. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists.

Competing interests may be financial or non-financial. A competing interest exists when the authors’ interpretation of data or presentation of information may be influenced by their personal or financial relationships with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.

Financial competing interests include (but are not limited to):

– Receiving reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of the article, either now or in the future.
– Holding stocks or shares in an organization that may in any way gain or lose financially from the publication of the article, either now or in the future.
– Holding, or currently applying for, patents relating to the content of the manuscript.
– Receiving reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript.
– Non-financial competing interests
– Non-financial competing interests include (but are not limited to) political, personal, religious, ideological, academic, and intellectual competing interests. If, after reading these guidelines, you are unsure whether you have a competing interest, please contact the Editor.

Authors from pharmaceutical companies, or other commercial organizations that sponsor clinical trials, should declare these as competing interests on submission. They should also adhere to the Good Publication Practice guidelines for pharmaceutical companies, which are designed to ensure that publications are produced in a responsible and ethical manner. The guidelines also apply to any companies or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations, and communications companies. Medprecis Publishers will not publish advertorial content.

Human and Animal Rights

All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s)’ institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.

Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to Editors on request. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, Editors may contact the ethics committee for further information.

If a study has not been submitted to an ethics committee prior to commencing, retrospective ethics approval usually cannot be obtained and it may not be possible to consider the manuscript for peer review. How to proceed in such cases is at the Editor(s)’ discretion.

Authors reporting the use of a new procedure or tool in a clinical setting, for example as a technical advance or case report, must give a clear justification in the manuscript for why the new procedure or tool was deemed more appropriate than usual clinical practice to meet the patient’s clinical need. Such justification is not required if the new procedure is already approved for clinical use at the authors’ institution. Authors will be expected to have obtained ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment.

Informed Consent

For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.

For all manuscripts that include details, images, or videos relating to individual participants, written informed consent for the publication of these must be obtained from the participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. If the participant has died, then consent for publication must be sought from the next of kin of the participant. This documentation must be made available to Editors on request and will be treated confidentially. In cases where images are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for publication of images may not be required. The final decision on whether consent to publish is required lies with the Editor.

Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.

A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption). The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.

For experimental studies involving client-owned animals, authors must also document informed consent from the client or owner and adherence to a high standard (best practice) of veterinary care.

Field studies and other non-experimental research on animals must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. A statement detailing compliance with relevant guidelines and/or appropriate permissions or licenses must be included in the manuscript. We recommend that authors comply with the Convention on the Trade in Endangered Species of Wild Fauna and Flora and the IUCN Policy Statement on Research Involving Species at Risk of Extinction.

Authors are strongly encouraged to conform to the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines, developed by the National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs), for reporting animal studies.

For studies reporting livestock trials with production, health, and food-safety outcomes, authors are encouraged to adhere to the Reporting Guidelines for Randomized Controlled Trials in Livestock and Food Safety (REFLECT).

Our Editors and Editorial Staff

Editors who make final editorial decisions on articles must have no financial, personal, or professional involvement with the manuscript under consideration. If a potential bias exists, they should withdraw from handling the paper. Editors will base decisions on the importance of the work and not on its potential effect on the Journal’s commercial success.

Editors are required to disclose any potential competing interests to the publisher, and editorial staff members are not permitted to use information obtained through working with manuscripts for private gain.

Article Rejection Policy

The editor can reject the articles if any scientific misconduct (duplicate submissions, article published in another journal, bogus claims of authorship, data fabrication, article plagiarism) is noticed. In an extremely limited number of cases, it may be necessary to remove an article from the online database. This will only occur where the article is clearly defamatory or infringes others’ legal rights, or where the article is, or we have good reason to expect it will be, the subject of a court order, or where the article if acted upon, might pose a serious health risk. In these circumstances, while the metadata (Title and Authors) will be retained, the text will be replaced with a screen indicating the article has been removed for legal reasons.

In case of any misconduct detected, Journal holds all rights to disclose the conduct of the authors along with manuscript detail and cannot be held responsible for any consequences arising from it.

 Manuscript Withdrawal Charges Policy

Withdrawal charges are applicable if authors wish to withdraw their papers at any stage during the review and publication process, they need to pay a withdrawal fee (45% of the actual publication charges). The publisher collects the withdrawal charges to cover the costs incurred for software and tools used for peer-reviewing, editing, publishing, maintaining & archiving. However, these charges are not applicable if the authors withdraw the paper within a week from the date of submission.

Why?

Sometimes, authors send a request mail to withdraw their manuscript after our publication process was over. If the withdrawal did a few days before submission, it is easy for us to handle. But if we receive the request very late, i.e., Nearby the publication date, it is very difficult to resolve it. Because withdrawal makes waste our resources and efforts invested in processing the manuscript by editors and reviews and our journal team editorial staff.

Article Retraction Policy

If the author wishes to withdraw the paper from a journal, the author needs to submit an “Article withdrawal Form" signed by all authors (or) the corresponding author of the manuscript stating the reasons for manuscript withdrawal. The form is available from the Editorial Office of the journal.

Article Refund Policy

Processing charges will not be refunded to authors once paid in case of article withdrawal/retraction/removal, as publishing incurs a lot of cost during the publication process and reverse transactions cannot be processed from the journal side.